Regulation of vascular endothelial growth factor by hypoxia and its modulation by the von Hippel-Lindau tumor suppressor gene

Kidney International

Volumn 51, Issue 2, 1997, Pages 575-578

  Levy, Andrew P ^b   Levy, Nina S ^b   Iliopoulos, Othon ^b   Jiang, Chian ^b   Kaelin Jr , William G ^b   Goldberg, Mark A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; VASCULOTROPIN;

ANGIOGENESIS; CONFERENCE PAPER; GENETIC TRANSCRIPTION; HUMAN; HYPOXIA; MODULATION; PRIORITY JOURNAL; REGULATORY MECHANISM; VON HIPPEL LINDAU DISEASE;

EID: 0031027287     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.82     Document Type: Conference Paper

References (28)

1. SHWEIKI D, ITIN A, SOFFER D, KESHET E: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angionenesis. Nature 359:843-845, 1992
2. SABRI MN, DISCIASCIO G, COWLEY MJ, ALPERT D, VETROVEC GW: Coronary collateral recruitment: Functional significance and relation to rate of vessel closure. Am Heart J 121:876-80, 1991
3. PLATE KH, BREIER G, WEICH HA, RISAU W: Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature 359:845-848, 1992
4. AIELLO LP, AVERY RL, ARRIGG PG, KEYT BA, JAMPEL HD, SHAH ST, PASQUALE LR, THIEME H, IWAMOTO MA, PARK JF, NGUYEN HV, AIELLO LM, FERRARA N, KING G: Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480-1487, 1994
5. LEVY AP, TAMARGO R, BREM H, NATHANS D: An endothelial cell growth factor from the mouse neuroblastoma cell line NB41. Growth Factors 2:9-19, 1989
6. LEUNG DW, CACHIANES G, KUANG WJ, GOEDDEL DV, FERRARA N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306-1309, 1989
7. KIM KJ, LI B, WINER J, ARMANINI M, GILLET N, PHILLIPS HS, FERRARA N: Inhibition of VEGF-induced angiogenesis suppresses tumor growth in vivo. Nature 362:841-844, 1993
8. GOLDBERG MA, SCHNEIDER TJ: Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J Biol Chem 269:4355-4359, 1994
9. LEVY AP, LEVY NS, LOSCALZO J, CALDERONE A, TAKAHASHI N, YEO K-T, KOREN G, COLUCCI WS, GOLDBERG MA: Regulation of vascular endothelial growth factor in cardiac myocytes. Circ Res 76:758-766, 1995
10. LEVY AP, LEVY NS, WEGNER S, GOLDBERG MA: Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem 270:13333-13340, 1995
11. GOLDBERG MA, DUNNING SP, BUNN HF: Regulation of the erythropoietin gene: Evidence that the oxygen sensor is a heme protein. Science 242:1412-1415, 1988
12. CLAFFEY KP, WILKISON WO, SPIEGELMAN BM: Vascular endothelial growth factor: Regulation by cell differentiation and activated second messenger pathways. J Biol Chem 267:16317-16322, 1992
13. STEIN I, NEEMAN M, SHWEIKI D, ITIN A, KESHET E: Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Mol Cell Biol 15:5363-5368, 1995
14. 2 tension. Proc Natl Acad Sci USA 92:5510-5514, 1995
15. WU X, DISCHER D, BISHOPRIC N, WEBSTER KA: Zinc fingers are redox sensors during acute oxidative stress. (abstract) Circ 90:1343A, 1994
16. ABATE C, LUK D, CURRAN T: Rapid regulation of fos and jun DNA-binding activity in vitro. Science 249:1157-1161, 1990
17. FIRTH J, EBERT B, RATCLIFFE P: Hypoxic regulation of lactate dehydrogenase A. J Biol Chem 270:21021-21027, 1995
18. SEMENZA GL, WANG GL: A nuclear factor induced by hypoxia via de novo protein wynthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 12:5447-5454, 1992
19. MADAN A, CURTIN PT: A 24-base pair sequence 3′ to the human erythropoietin gene contains a hypoxia-responsive transcriptional enhancer. Proc Natl Acad Sci USA 90:3928-3932, 1993
20. BLANCHARD KL, ACOUAVIVA AM, GALSON DL, BUNN HF: Hypoxic induction of the human erythropoietin gene: Cooperation between the promoter and enhancer, each of which contains steroid receptor response elements. Mol Cell Biol 12:5373-5385, 1992
21. SHIMA DT, DEUTSCH U, D'AMORE PA: Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability. FEBS Lett 370:203-208, 1995
22. WHITE FC, CARROLL SM, KAMPS MP: VEGF mRNA is reversibly stabilized by hypoxia and persistently stabilized in VEGF-overexpressing human tumor cell lines. Growth Factors 12:289-301, 1995
23. LEVY AP, LEVY NS, GOLDBERG MA: Post-transcriptional regulation of rascular endothelial growth factor by hypoxia. J Biol Chem 271: 2746-2753, 1996
24. SHAW G, KAMEN R: A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46:659-667, 1986
25. LAGNADO CA, BROWN CY, GOODALL GJ: AUUUA is not sufficient to promote poly(A) shortening and degradation of an mRNA: The functional sequence within AU-rich elements may be UUAUUUA(A/ U) (A/U). Mol Cell Biol 14:7984-7995, 1994
26. ZUBIAGA AM, BELASCO JG, GREENBERG ME: The nonamer UUAUUUAUU is the key AU-rich sequence motif that mediates mRNA degradation. Mol Cell Biol 15:2219-2230, 1995
27. CZYZYK-KRZESKA MF, DOMINSKI Z, KOLE R, MILLHORN DE: Hypoxia stimulates binding of a cytoplasic protein to a pyrimidine-rich sequence in the 3′-untranslated region of rat tyrosine hydroxylase mRNA. J Biol Chem 269:9940-9945, 1994
28. ILIOPOULOS O, LEVY AP, JIANG, C, KAELIN WG, GOLDBERG MA: Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc Natl Acad Sci USA 93:10595-10599, 1996